Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.320
+0.130 (5.98%)
Nov 7, 2024, 3:29 PM EST - Market open
Lexaria Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Lexaria Bioscience stock have an average target of 11, with a low estimate of 10 and a high estimate of 12. The average target predicts an increase of 374.14% from the current stock price of 2.32.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 18, 2024.
Analyst Ratings
The average analyst rating for LEXX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +331.03% | Jul 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +331.03% | Jul 10, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $3 → $12 | Strong Buy | Maintains | $3 → $12 | +417.24% | Mar 5, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | -13.79% | Jul 21, 2023 |
Financial Forecast
Revenue This Year
411.74K
from 226.21K
Increased by 82.02%
Revenue Next Year
803.25K
from 411.74K
Increased by 95.09%
EPS This Year
-0.64
from -1.01
EPS Next Year
-0.40
from -0.64
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 556,500 | 1.0M | 1.2M | |||
| Avg | 411,743 | 803,250 | 1.2M | |||
| Low | 147,980 | 588,000 | 1.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 146.0% | 148.7% | 52.8% | |||
| Avg | 82.0% | 95.1% | 48.4% | |||
| Low | -34.6% | 42.8% | 42.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.42 | -0.35 | -0.36 |
| Avg | -0.64 | -0.40 | -0.48 |
| Low | -0.99 | -0.47 | -0.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.